ExoCoBio

Our Exosomes Your Future

ExoCoBio was founded in 2017, is headquartered in Seoul, South Korea, lists 51–200 employees, and has $9.3M in recorded funding across 1 round.

Headquarters
Seoul
Employees
51–200
Founded
2017
Business Model
B2B2C
Total Funding
$9.3M
Last Round
$9.3M Series CAug 2020
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

ExoCoBio is a Seoul-based biotechnology company and global leader in the development of exosome-based cosmeceutical and biopharmaceutical products. The company's proprietary ExoSCRT™ technology enables the production of high-purity, high-efficacy exosomes used across regenerative aesthetics, therapeutic, and immuno-oncology applications. ExoCoBio's product portfolio spans professional skin and hair care lines (ASCE+), consumer cosmetics, and bio-ingredient raw materials (ExoBRID, Vexosome, Rose Exosome) licensed to cosmetics manufacturers worldwide. On the pharmaceutical side, the company advances regenerative therapeutics and immuno-oncology pipelines leveraging exosome biology. In 2023, ExoCoBio entered a business combination with BENEV, achieving combined revenues of approximately KRW 68 billion.

Summary

ExoCoBio is a Biotech company based in Seoul, South Korea, founded in 2017. It lists 51–200 employees. It has raised $9.3M in total across 1 round, most recently a $9.3M Series C round in Aug 2020. Investors include K2 Investment Partners, SBI Investment Korea and DT & Investment.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CAug 2020
$9.3M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ExoCoBio on Indexed.vc
<a href="https://indexed.vc/companies/exocobio"><img src="https://indexed.vc/api/badge/company/exocobio" alt="ExoCoBio on Indexed.vc" width="260" height="76" /></a>